{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:26Z","timestamp":1791721586230,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007104","name":"Trakya \u00dcniversitesi","doi-asserted-by":"publisher","award":["2020-01"],"award-info":[{"award-number":["2020-01"]}],"id":[{"id":"10.13039\/501100007104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02062-1","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T20:29:59Z","timestamp":1685651399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pretreatment of prostate cancer cells with salinomycin and Wnt inhibitor increases the efficacy of cabazitaxel by inducing apoptosis and decreasing cancer stem cells"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7493-0388","authenticated-orcid":false,"given":"Riza","family":"Serttas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-6293","authenticated-orcid":false,"given":"Suat","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"3","key":"2062_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"2062_CR2","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","volume":"6","author":"A Mitra","year":"2015","unstructured":"Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015;6(13):10697\u2013711.","journal-title":"Oncotarget"},{"issue":"9","key":"2062_CR3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14656566.2022.2033210","volume":"23","author":"EM Yu","year":"2022","unstructured":"Yu EM, Aragon-Ching JB. Advances with androgen deprivation therapy for prostate cancer. Expert Opin Pharmacother. 2022;23(9):1015\u201333.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2062_CR4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clgc.2019.12.019","volume":"18","author":"DJ George","year":"2020","unstructured":"George DJ, et al. Treatment patterns and outcomes in patients with metastatic castration-resistant prostate cancer in a real-world clinical practice setting in the United States. Clin Genitourin Cancer. 2020;18(4):284\u201394.","journal-title":"Clin Genitourin Cancer"},{"key":"2062_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.789319","author":"JR Chen","year":"2022","unstructured":"Chen JR, et al. Comparison of systemic treatments for metastatic castration-resistant prostate cancer after docetaxel failure: a systematic review and network meta-analysis. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2021.789319.","journal-title":"Front Pharmacol"},{"key":"2062_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-015-0221-1","volume":"15","author":"KO Alfarouk","year":"2015","unstructured":"Alfarouk KO, et al. Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp. Cancer Cell Int. 2015;15:71\u201371.","journal-title":"Cancer Cell Int"},{"key":"2062_CR7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.12688\/f1000research.15382.1","volume":"7","author":"C Ritch","year":"2018","unstructured":"Ritch C, Cookson M. Recent trends in the management of advanced prostate cancer. F1000Res. 2018;7:1513.","journal-title":"F1000Res"},{"key":"2062_CR8","doi-asserted-by":"crossref","first-page":"116781","DOI":"10.1016\/j.lfs.2019.116781","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Mortezaee K, Majidpoor J. Cancer stem cell (CSC) resistance drivers. Life Sci. 2019;234:116781.","journal-title":"Life Sci"},{"issue":"8","key":"2062_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe N, et al. Targeting notch, hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12(8):445\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"2062_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-12-378612-8.00246-8","volume-title":"Encyclopedia of food safety","author":"A Anad\u00f3n","year":"2014","unstructured":"Anad\u00f3n A, Mart\u00ednez-Larra\u00f1aga MR. Veterinary drugs residues: coccidiostats. In: Motarjemi Y, editor. Encyclopedia of food safety. Waltham: Academic Press; 2014. p. 63\u201375."},{"issue":"3","key":"2062_CR11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.2010.01089.x","volume":"162","author":"JH Kim","year":"2011","unstructured":"Kim JH, et al. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol. 2011;162(3):773\u201384.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2062_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645\u201359.","journal-title":"Cell"},{"issue":"3","key":"2062_CR13","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3892\/etm.2021.10378","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, et al. Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling. Exp Ther Med. 2021;22(3):946.","journal-title":"Exp Ther Med"},{"issue":"33","key":"2062_CR14","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1002\/chem.202000335","volume":"26","author":"A Versini","year":"2020","unstructured":"Versini A, et al. Salinomycin derivatives kill breast cancer stem cells by lysosomal iron targeting. Chemistry. 2020;26(33):7416\u201324.","journal-title":"Chemistry"},{"issue":"3","key":"2062_CR15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/med.21870","volume":"42","author":"D Qi","year":"2022","unstructured":"Qi D, et al. Salinomycin as a potent anticancer stem cell agent: state of the art and future directions. Med Res Rev. 2022;42(3):1037\u201363.","journal-title":"Med Res Rev"},{"issue":"6","key":"2062_CR16","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1007\/s11033-022-07343-y","volume":"49","author":"S Erdogan","year":"2022","unstructured":"Erdogan S, et al. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+prostate cancer cells by downregulating wnt, NF-kappa B and AKT signaling. Mol Biol Rep. 2022;49(6):4873\u201384.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"2062_CR17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/cells8080826","volume":"8","author":"LF Ng","year":"2019","unstructured":"Ng LF, et al. WNT signaling in disease. Cells. 2019;8(8):826.","journal-title":"Cells"},{"issue":"1","key":"2062_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"key":"2062_CR19","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1038\/oncsis.2015.35","volume":"4","author":"A Borah","year":"2015","unstructured":"Borah A, et al. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis. 2015;4:e177.","journal-title":"Oncogenesis"},{"issue":"14","key":"2062_CR20","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-10-1028","volume":"70","author":"K Ewan","year":"2010","unstructured":"Ewan K, et al. A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res. 2010;70(14):5963\u201373.","journal-title":"Cancer Res"},{"key":"2062_CR21","doi-asserted-by":"crossref","first-page":"113674","DOI":"10.1016\/j.ecoenv.2022.113674","volume":"239","author":"SF Fu","year":"2022","unstructured":"Fu SF, et al. N-methyl-N-nitrosourea induces zebrafish anomalous angiogenesis through Wnt\/\u03b2-Catenin pathway. Ecotoxicol Environ Saf. 2022;239:113674.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2062_CR22","doi-asserted-by":"crossref","first-page":"204173141665083","DOI":"10.1177\/2041731416650838","volume":"7","author":"AH Fronk","year":"2016","unstructured":"Fronk AH, Vargis E. Methods for culturing retinal pigment epithelial cells: a review of current protocols and future recommendations. J Tissue Eng. 2016;7:2041731416650838.","journal-title":"J Tissue Eng"},{"issue":"2","key":"2062_CR23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0014-4827(84)90178-2","volume":"154","author":"MS Oka","year":"1984","unstructured":"Oka MS, Landers RA, Bridges CD. A serum-free defined medium for retinal pigment epithelial cells. Exp Cell Res. 1984;154(2):537\u201347.","journal-title":"Exp Cell Res"},{"issue":"3","key":"2062_CR24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.21873\/invivo.12408","volume":"35","author":"CY Su","year":"2021","unstructured":"Su CY, et al. Analyzing the expression of biomarkers in prostate cancer cell lines. In Vivo. 2021;35(3):1545\u20138.","journal-title":"In Vivo"},{"key":"2062_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13253","author":"S Erdogan","year":"2020","unstructured":"Erdogan S, Turkekul K. Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK\/JNK activation. J Food Biochem. 2020. https:\/\/doi.org\/10.1111\/jfbc.13253.","journal-title":"J Food Biochem"},{"issue":"1","key":"2062_CR26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12935-021-01853-8","volume":"21","author":"SJ Han","year":"2021","unstructured":"Han SJ, Kwon S, Kim KS. Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int. 2021;21(1):152.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2062_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/bjc.2011.530","volume":"106","author":"K Ketola","year":"2012","unstructured":"Ketola K, et al. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer. 2012;106(1):99\u2013106.","journal-title":"Br J Cancer"},{"issue":"5","key":"2062_CR28","first-page":"630","volume":"16","author":"Q Liu","year":"2021","unstructured":"Liu Q, et al. Salinomycin suppresses tumorigenicity of liver cancer stem cells and Wnt\/Beta-catenin signaling. Curr Stem Cell Res Ther. 2021;16(5):630\u20137.","journal-title":"Curr Stem Cell Res Ther"},{"key":"2062_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tiv.2019.05.004","volume":"60","author":"M Tyagi","year":"2019","unstructured":"Tyagi M, Patro BS. Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation. Toxicol In Vitro. 2019;60:125\u201333.","journal-title":"Toxicol In Vitro"},{"key":"2062_CR30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cbi.2018.09.018","volume":"296","author":"L Liu","year":"2018","unstructured":"Liu L, et al. Salinomycin suppresses cancer cell stemness and attenuates TGF-beta-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Chem Biol Interact. 2018;296:145\u201353.","journal-title":"Chem Biol Interact"},{"issue":"8","key":"2062_CR31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cells8080926","volume":"8","author":"L Barbato","year":"2019","unstructured":"Barbato L, et al. Cancer stem cells and targeting strategies. Cells. 2019;8(8):926.","journal-title":"Cells"},{"issue":"3","key":"2062_CR32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s13402-021-00591-3","volume":"44","author":"AP Patni","year":"2021","unstructured":"Patni AP, et al. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma-clinical implications. Cell Oncol. 2021;44(3):473\u201394.","journal-title":"Cell Oncol"},{"issue":"2","key":"2062_CR33","doi-asserted-by":"crossref","first-page":"e0211916","DOI":"10.1371\/journal.pone.0211916","volume":"14","author":"J Klose","year":"2019","unstructured":"Klose J, et al. Salinomycin: anti-tumor activity in a pre-clinical colorectal cancer model. PLoS ONE. 2019;14(2):e0211916.","journal-title":"PLoS ONE"},{"issue":"4","key":"2062_CR34","first-page":"1991","volume":"39","author":"T Gehrke","year":"2018","unstructured":"Gehrke T, et al. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro. Oncol Rep. 2018;39(4):1991\u20138.","journal-title":"Oncol Rep"},{"issue":"6","key":"2062_CR35","doi-asserted-by":"crossref","first-page":"e66931","DOI":"10.1371\/journal.pone.0066931","volume":"8","author":"K Arafat","year":"2013","unstructured":"Arafat K, et al. Inhibitory effects of salinomycin on cell survival, colony growth, migration, and invasion of human non-small cell lung cancer A549 and LNM35: involvement of NAG-1. PLoS ONE. 2013;8(6):e66931.","journal-title":"PLoS ONE"},{"key":"2062_CR36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bcp.2019.04.026","volume":"164","author":"J Dewangan","year":"2019","unstructured":"Dewangan J, et al. Salinomycin inhibits breast cancer progression via targeting HIF-1alpha\/VEGF mediated tumor angiogenesis in vitro and in vivo. Biochem Pharmacol. 2019;164:326\u201335.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2062_CR37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","volume":"117","author":"M Raisova","year":"2001","unstructured":"Raisova M, et al. The Bax\/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-mediated apoptosis. J Invest Dermatol. 2001;117(2):333\u201340.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"2062_CR38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/ijms18051088","volume":"18","author":"KY Kim","year":"2017","unstructured":"Kim KY, et al. Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K\/AKT\/mTOR and ERK\/p38 MAPK-dependent signaling in human prostate cancer cells. Int J Mol Sci. 2017;18(5):1088.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2062_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbrc.2011.08.054","volume":"413","author":"KY Kim","year":"2011","unstructured":"Kim KY, et al. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun. 2011;413(1):80\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2062_CR40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/onc.2015.117","volume":"35","author":"SH Lee","year":"2016","unstructured":"Lee SH, et al. Androgen signaling is a confounding factor for beta-catenin-mediated prostate tumorigenesis. Oncogene. 2016;35(6):702\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"2062_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2020.04.112","volume":"527","author":"F Wang","year":"2020","unstructured":"Wang F, et al. Wnt\/beta-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation. Biochem Biophys Res Commun. 2020;527(1):242\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2062_CR42","doi-asserted-by":"crossref","first-page":"116816","DOI":"10.1016\/j.lfs.2019.116816","volume":"254","author":"P Bian","year":"2020","unstructured":"Bian P, et al. Activated Wnt\/f3-catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer. Life Sci. 2020;254:116816.","journal-title":"Life Sci"},{"issue":"4","key":"2062_CR43","first-page":"3154","volume":"20","author":"F Fang","year":"2020","unstructured":"Fang F, et al. CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt\/beta-catenin pathway. Exp Ther Med. 2020;20(4):3154\u201360.","journal-title":"Exp Ther Med"},{"issue":"1","key":"2062_CR44","doi-asserted-by":"crossref","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","volume":"9","author":"JQ Liao","year":"2014","unstructured":"Liao JQ, et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS ONE. 2014;9(1):e84941.","journal-title":"PLoS ONE"},{"key":"2062_CR45","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e14","author":"HG Lee","year":"2017","unstructured":"Lee HG, et al. Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell. J Gynecol Oncol. 2017. https:\/\/doi.org\/10.3802\/jgo.2017.28.e14.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2062_CR46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5(1):8.","journal-title":"Signal Transduct Target Ther"},{"key":"2062_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08841-1","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt\/beta-catenin signal pathway in prostate cancer cells. BMC Cancer. 2021. https:\/\/doi.org\/10.1186\/s12885-021-08841-1.","journal-title":"BMC Cancer"},{"issue":"16","key":"2062_CR48","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/onc.2010.560","volume":"30","author":"X Yu","year":"2011","unstructured":"Yu X, et al. Wnt\/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene. 2011;30(16):1868\u201379.","journal-title":"Oncogene"},{"issue":"6","key":"2062_CR49","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1096\/fj.09-151639","volume":"24","author":"MG Mendez","year":"2010","unstructured":"Mendez MG, Kojima S, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010;24(6):1838\u201351.","journal-title":"FASEB J"},{"issue":"1","key":"2062_CR50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40880-017-0203-x","volume":"36","author":"W Wang","year":"2017","unstructured":"Wang W, et al. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Chin J Cancer. 2017;36(1):35.","journal-title":"Chin J Cancer"},{"issue":"2","key":"2062_CR51","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/0008-5472.CAN-05-1988","volume":"66","author":"SE Witta","year":"2006","unstructured":"Witta SE, et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006;66(2):944\u201350.","journal-title":"Cancer Res"},{"issue":"2","key":"2062_CR52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.18632\/oncotarget.2841","volume":"6","author":"Z Shang","year":"2015","unstructured":"Shang Z, et al. A switch from CD44(+) cell to EMT cell drives the metastasis of prostate cancer. Oncotarget. 2015;6(2):1202\u201316.","journal-title":"Oncotarget"},{"issue":"7","key":"2062_CR53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.apjtm.2015.06.004","volume":"8","author":"H Qu","year":"2015","unstructured":"Qu H, et al. Effect of salinomycin on metastasis and invasion of bladder cancer cell line T24. Asian Pac J Trop Med. 2015;8(7):578\u201382.","journal-title":"Asian Pac J Trop Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02062-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02062-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:18:05Z","timestamp":1687900685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02062-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02062-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial, personal, or professional conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This article does not contain any studies with human participants or live animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"194"}}